← Leaderboards
Peter W Heymann
University Of Virginia Charlottesville
$2,984,514
Attributed
$5,668,265
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,668,265 · 6
By mechanism
U01$5,259,835 · 1
M01$327,680 · 3
R03$80,750 · 1
P01$0 · 1
Top collaborators
- Thomas A. Platts-Mills4 shared
- Larry C Borish1 shared
- Mark R Conaway1 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Judith A Woodfolk$11,051,284
- Larry C Borish$12,170,802
- Gary P Rakes$125,170
- Ronald B Turner$2,212,762
- John F Hunt$2,491,904
Others in their field
Top investigators on “Rhinovirus”
- Fernando D Martinez · University Of Arizona$26,976,656
- Wanda Phipatanakul · Boston Children'S Hospital$21,005,199
- Sayera Banu · International Ctr/Diarrhoeal Dis Res$17,357,415
- Carlos A. Camargo · Brigham And Women'S Hospital$17,190,054
- James E. Gern · University Of Wisconsin-Madison$15,152,627
- Marc B Hershenson · University Of Chicago$13,487,987
Research focus
RhinovirusRespiratory SystemViralInfectionAllergicInvestigationResponseSymptomsAsthmaRespiratory Tract StructureMeasurementIn VivoBloodAllergic InflammationLower Respiratory Tract StructureMonitorInflammationHealth Care CostsAnti-IgeImmuneInsightEosinophilAirway InflammationDesign
Grant awards (10)
Exploring innate immune responses to rhinovirus in allergic asthma$80,750
R03 · FY2025 · AI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,591,510
U01 · FY2015 · AI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,343,673
U01 · FY2014 · AI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,114,692
U01 · FY2013 · AI
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a$1,209,960
U01 · FY2012 · AI
VIRAL REPLICATION, CLEARANCE IN ASTHMATICS, NON-ASTHMATICS-RHINOVIRUS CHALLENGE$100,231
M01 · FY2010 · RR · contact PI
VIRAL REPLICATION, CLEARANCE IN ASTHMATICS, NON-ASTHMATICS-RHINOVIRUS CHALLENGE$125,763
M01 · FY2009 · RR · contact PI
VIRAL REPLICATION, CLEARANCE IN ASTHMATICS, NON-ASTHMATICS-RHINOVIRUS CHALLENGE$101,686
M01 · FY2008 · RR · contact PI
Viruses and IgE in relation to mechanisms of asthma$0
P01 · FY2002 · AI
Viruses and IgE in relation to mechanisms of asthma$0
P01 · FY2001 · AI